| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Alder Biopharmaceutl | 657,783 | 34,843,000 | 23.09% | ||
| 2 | VERSARTIS INC COM | 2,039,223 | 31,037,000 | 20.57% | ||
| 3 | Oxford Immunotec Global PLC | 1,377,497 | 19,078,000 | 12.64% | ||
| 4 | CHIMERIX INC | 320,608 | 14,812,000 | 9.82% | ||
| 5 | DYNAVAX TECHNOLOGIES CORP | 612,498 | 14,348,000 | 9.51% | ||
| 6 | MARINUS PHARMACEUTICALS INC | 653,494 | 7,581,000 | 5.02% | ||
| 7 | ACADIA PHARMACEUTICALS INC COM | 177,230 | 7,422,000 | 4.92% | ||
| 8 | RELYPSA INC | 221,204 | 7,320,000 | 4.85% | ||
| 9 | Esperion Therapeutics Inc | 49,816 | 4,073,000 | 2.70% | ||
| 10 | KARYOPHARM THERAPEUTICS INC COM | 126,687 | 3,447,000 | 2.28% | ||
| 11 | ACCELERON PHARMA INC | 89,738 | 2,839,000 | 1.88% | ||
| 12 | DERMIRA INC | 131,590 | 2,309,000 | 1.53% | ||
| 13 | CALITHERA BIOSCIENCES INC | 135,890 | 970,000 | 0.64% | ||
| 14 | ACHAOGEN INC COM | 132,728 | 800,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001631614-15-000003, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
